Stocks
Immunome (IMNM) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -10.3 | -12.3 | -25.2 | -36.9 | -109.5 | -317.5 | |||
| Changes by years, y/y, % | +34% | +18% | +106% | +46% | +197% | +69.9% | |||
Immunome. Operating Income, bln rub
Immunome. Operating Income, changes, %
Immunome. Operating Income, sum by quarters, bln rub
Immunome (IMNM) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -4.63 | -94.7 | -132.3 | -40.0 | -50.5 | -317.5 | ||
| Changes by years, y/y, % | -46% | +1 116% | +2 859% | +593% | +990% | |||
| Changes by quarters, q/q, % | -20% | +1 943% | +40% | -70% | +26% | |||
